TNP-2092 Completed Phase 2 Trials for Skin and Subcutaneous Tissue Bacterial Infections / Gram Positive Bacterial Infections Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03964493TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection